Brocard A - Search Results

1

Innate immunity: a crucial target for zinc in the treatment of inflammatory dermatosis.

Brocard A, Dréno B. Brocard A, et al. J Eur Acad Dermatol Venereol. 2011 Oct;25(10):1146-52. doi: 10.1111/j.1468-3083.2010.03934.x. Epub 2011 Jan 24. J Eur Acad Dermatol Venereol. 2011. PMID: 21261748 Review.

2

Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baseline.

Knol AC, Vallée A, Herbreteau G, Nguyen JM, Varey E, Gaultier A, Théoleyre S, Saint-Jean M, Peuvrel L, Brocard A, Quéreux G, Khammari A, Denis MG, Dréno B. Knol AC, et al. Among authors: brocard a. Exp Dermatol. 2016 Oct;25(10):783-8. doi: 10.1111/exd.13065. Exp Dermatol. 2016. PMID: 27194447

3

Hidradenitis suppurativa: the role of deficient cutaneous innate immunity.

Dréno B, Khammari A, Brocard A, Moyse D, Blouin E, Guillet G, Léonard F, Knol AC. Dréno B, et al. Among authors: brocard a. Arch Dermatol. 2012 Feb;148(2):182-6. doi: 10.1001/archdermatol.2011.315. Epub 2011 Oct 17. Arch Dermatol. 2012. PMID: 22004878

4

Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metastatic melanoma.

Knol AC, Nguyen JM, Quéreux G, Brocard A, Khammari A, Dréno B. Knol AC, et al. Among authors: brocard a. Exp Dermatol. 2011 May;20(5):430-4. doi: 10.1111/j.1600-0625.2011.01260.x. Epub 2011 Mar 16. Exp Dermatol. 2011. PMID: 21410773

5

Is a single BRAF wild-type test sufficient to exclude melanoma patients from vemurafenib therapy?

Saint-Jean M, Quéreux G, Nguyen JM, Peuvrel L, Brocard A, Vallée A, Knol AC, Khammari A, Denis MG, Dréno B. Saint-Jean M, et al. Among authors: brocard a. J Invest Dermatol. 2014 May;134(5):1468-1470. doi: 10.1038/jid.2013.378. Epub 2013 Sep 11. J Invest Dermatol. 2014. PMID: 24025553 No abstract available.

6

Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.

Knol AC, Quéreux G, Brocard A, Ballanger F, Khammari A, Nguyen JM, Dréno B. Knol AC, et al. Among authors: brocard a. Exp Dermatol. 2010 Aug;19(8):e95-102. doi: 10.1111/j.1600-0625.2009.00993.x. Exp Dermatol. 2010. PMID: 19845755

7

Bexarotene in cutaneous T-cell lymphoma: third retrospective study of long-term cohort and review of the literature.

Quéreux G, Saint-Jean M, Peuvrel L, Brocard A, Knol AC, Dréno B. Quéreux G, et al. Among authors: brocard a. Expert Opin Pharmacother. 2013 Sep;14(13):1711-21. doi: 10.1517/14656566.2013.810718. Epub 2013 Jul 10. Expert Opin Pharmacother. 2013. PMID: 23837676

8

Clinical, Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant Recipients.

Brocard A, Knol AC, Bossard C, Denis MG, Quéreux G, Saint-Jean M, Peuvrel L, Khammari A, Blancho G, Dantal J, Dréno B. Brocard A, et al. Acta Derm Venereol. 2017 Apr 6;97(4):483-488. doi: 10.2340/00015555-2568. Acta Derm Venereol. 2017. PMID: 27868139 Free article.

9

Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature.

Quéreux G, Brocard A, Saint-Jean M, Peuvrel L, Knol AC, Allix R, Khammari A, Renaut JJ, Dréno B. Quéreux G, et al. Among authors: brocard a. J Am Acad Dermatol. 2013 Dec;69(6):890-7. doi: 10.1016/j.jaad.2013.07.047. Epub 2013 Sep 14. J Am Acad Dermatol. 2013. PMID: 24041738 Review.

10

Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.

Quéreux G, Renaut JJ, Peuvrel L, Knol AC, Brocard A, Dréno B. Quéreux G, et al. Among authors: brocard a. Acta Derm Venereol. 2010 Nov;90(6):616-20. doi: 10.2340/00015555-0978. Acta Derm Venereol. 2010. PMID: 21057746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results